Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An expanded access programme for prior and concurrent use of abiraterone and enzalutamide with Ra-223

Trial Profile

An expanded access programme for prior and concurrent use of abiraterone and enzalutamide with Ra-223

Status: Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 16 Sep 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Radium 223 chloride (Primary) ; Abiraterone; Enzalutamide
  • Indications Prostate cancer
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 14 Sep 2015 Safety and overall survival results will be presented at the 2015 European Cancer Congress, according to Bayer media release.
    • 26 Feb 2015 New trial record
    • 23 Feb 2015 According to a Bayer HealthCare Pharmaceuticals media release, data from this study will be presented at the 2015 Genitourinary Cancers Symposium of the American Society of Clinical Oncology (ASCO GU).
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top